Hēlo PE Thrombectomy System developed by U.S. medical device company Endovascular Engineering.

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.

May 6, 2024
Interventional cardiologist James B. Hermiller, MD, is officially the new president of the Society for Cardiovascular Angiography & Interventions (SCAI) form 2024-2025. #SCAI #SCAI24 #SCAI2024.

SCAI president begins term on optimistic note: ‘Our field’s future is brighter than ever’

Interventional cardiologist James B. Hermiller, MD, officially assumed the position at the end of SCAI 2024 Scientific Sessions.

May 6, 2024
The DurAVR TAVR system from Anteris Technologies. A new biomimetic transcatheter aortic valve replacement (TAVR) system from Anteris Technologies could provide cardiologists with a new way to treat severe aortic stenosis (AS), according to new one-year data presented at SCAI 2024 Scientific Sessions, the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). The DurAVR TAVR system, made from a single piece of anti-calcification ADAPT tissue patented by Anteris.

New-look TAVR valve shows early promise in patients with severe AS

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

May 3, 2024
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock

TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options. 

May 3, 2024
ACC President Cathie Biga explains how cardiologist employment models undergoing a profound transformation during an interview with Cardiovascular Digital Editor Dave Fornell at ACC 2024.

What happened to cardiology's private practices?

Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.

May 3, 2024
PCI interventional cardiology. The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients. 

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients. 

May 2, 2024
Cardiac surgeons and interventional cardiologists in China have completed the very first-in-man robot-assisted transcatheter edge-to-edge repair (TEER). It was guided entirely with echo and completed in less than 40 minutes in China. (A)Three-compartment of robotic transcatheter edge-to-edge repair (TEER) system.

Cardiologists and surgeons perform world’s first robot-assisted TEER

A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.

May 2, 2024
Sunil Rao, MD, NYU, explains the DANGER-SHOCK trial at ACC 2024 and how it may help improve cardiogenic shock survival.

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock. 

May 1, 2024